Bortezomib, Lenalidomide and Dexamethasone Combination Induced Complete Remission in Relapsed/Refractory Plasmablastic Lymphoma: Case Report of a Potential Novel Treatment Approach

Plasmablastic lymphoma is a rare subtype of large B-cell lymphoma characterised by an aggressive clinical course with frequent relapses and refractoriness to chemotherapy. It is usually associated with HIV, however, it can also be seen in immunocompetent patients. It has distinct pathological charac...

Descripción completa

Detalles Bibliográficos
Autores principales: Sabry, Waleed, Wu, Yue, Kodad, Shruthi Ganeshappa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323819/
https://www.ncbi.nlm.nih.gov/pubmed/35877259
http://dx.doi.org/10.3390/curroncol29070399

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9323819/
https://www.ncbi.nlm.nih.gov/pubmed/35877259
http://dx.doi.org/10.3390/curroncol29070399

Ejemplares similares